CURIA BAGS 2024 CDMO LEADERSHIP AWARD FOR ITS SERVICE

KUALA LUMPUR, Feb 6 (Bernama) -- Curia, a contract research, development and manufacturing organisation (CDMO), has been awarded a 2024 CDMO Leadership Award in the Service category, Small Pharma group.

In a statement, Curia said the awards, in its 13th year, are presented by Outsourced Pharma and Life Science Leader.

Curia Chief Executive Officer, Philip Macnabb said the company is honoured to receive this award.

“This distinction underscores our commitment to creating value for our customers across all of our R&D and manufacturing offerings, and we are especially appreciative to be acknowledged by the partners we support for that commitment,” he said.

Winners of CDMO Leadership Awards are selected based on market research by Industry Standard Research (ISR) to distinguish CDMOs that meet or exceed customer expectations.

For the 2024 awards, 98 contract manufacturers were evaluated by 23 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey.

Respondents to the survey only evaluate companies with which they have worked on an outsourced project within the past 18 months, and Curia was awarded based on the feedback of respondents in the Small Pharma category.

As a CDMO with over 30 years of experience, Curia is an integrated network of 27 global sites and over 3,500 employees partnering with biopharmaceutical customers to bring life-changing therapies to market.

-- BERNAMA